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Abstract
By means of a novel methodology that can statistically derive patterns of co-alterations distri-
bution from voxel-based morphological data, this study analyzes the patterns of brain
alterations of three important psychiatric spectra—that is, schizophrenia spectrum disorder
(SCZD), autistic spectrum disorder (ASD), and obsessive-compulsive spectrum disorder
(OCSD). Our analysis provides five important results. First, in SCZD, ASD, and OCSD brain
alterations do not distribute randomly but, rather, follow network-like patterns of co-
alteration. Second, the clusters of co-altered areas form a net of alterations that can be defined
as morphometric co-alteration network or co-atrophy network (in the case of gray matter
decreases). Third, within this network certain cerebral areas can be identified as pathoconnec-
tivity hubs, the alteration of which is supposed to enhance the development of neuronal
abnormalities. Fourth, within the morphometric co-atrophy network of SCZD, ASD, and OCSD,
a subnetwork composed of eleven highly connected nodes can be distinguished. This subnet-
work encompasses the anterior insulae, inferior frontal areas, left superior temporal areas, left
parahippocampal regions, left thalamus and right precentral gyri. Fifth, the co-altered areas
also exhibit a normal structural covariance pattern which overlaps, for some of these areas (like
the insulae), the co-alteration pattern. These findings reveal that, similarly to neurodegenera-
tive diseases, psychiatric disorders are characterized by anatomical alterations that distribute
according to connectivity constraints so as to form identifiable morphometric co-atrophy
patterns.
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1 | INTRODUCTION
The anatomical co-alteration networking analysis is an intriguing and
promising new field of connectomics, which can be defined as the study
of the network patterns according to which structural alterations distrib-
ute across the brain (Yates, 2012). In other words, the networking analysis
of brain disorders aims to give a description of networks formed by co-
altered (or co-atrophic, in the case of grey matter (GM) decreases) cere-
bral regions. Recent studies in this field show that brain alterations are
rarely confined to a single cerebral area, but rather tend to distribute to
many different sites. Often brain areas in which alterations co-occur also
exhibit patterns of anatomical covariance (Evans, 2013). Furthermore,
converging evidence suggests that pathological alterations caused by
brain disorders are likely to follow patterns of distribution that strongly
have a network-like architecture, which depends on the organization of
both the structural and functional connectivity (Cauda, et al., 2017;
Cauda, et al., 2012b; Crossley, et al., 2016; Crossley, et al., 2014; Fornito,
Zalesky, & Breakspear, 2015; Menon, 2013; Raj, Kuceyeski, & Weiner,
2012; Saxena & Caroni, 2011; Seeley, Crawford, Zhou, Miller, & Greicius,
2009; Yates, 2012; Zhou, Gennatas, Kramer, Miller, & Seeley, 2012).
Hum Brain Mapp. 2018;1–31. wileyonlinelibrary.com/journal/hbm VC 2018Wiley Periodicals, Inc. | 1
Received: 8 May 2017 | Revised: 19 December 2017 | Accepted: 28 December 2017
DOI: 10.1002/hbm.23952
This new field of research is destined to provide invaluable insight
in the understanding and diagnosis of brain disorders. Thus far the
diagnosis of neuropsychiatric conditions relies entirely on the observa-
tion of constellations of behavioral signs and symptoms. However,
these diagnostic procedures do not seem to have clear relations to the
underlying biological processes that should be the targets of medical
treatments (Poldrack & Farah, 2015). What is more, this approach can
result in heterogeneity within diagnostic categories and in poor inter-
rater reliability for many clinical evaluations, which in turn produces a
negative impact on clinical outcomes (Freedman, et al., 2013).
Even the fifth recent version of the DSM still lacks a rigorous neuro-
biological basis. This is why the US National Institute of Mental Health
Research Domain Criteria (RDoC, http://www.nimh.nih.gov/research-pri-
orities/rdoc/index.shtml; Insel, 2010, 2014) has suggested to construct a
map of relationships between symptoms’ manifestations and wide biolog-
ical realms, so as to improve both the homogeneity and reliability of brain
disorders’ classification. The aim of RDoC is to go beyond the old impre-
cise pathological categories and give the clinicians more reliable diagnos-
tic tools. Recent studies that are consistent with this line of thought have
already tried to identify important biomarkers capable of defining classes
of patients independently of their symptomatic manifestations (Clementz,
et al., 2016; Marquand, Rezek, Buitelaar, & Beckmann, 2016).
The case of schizophrenia (SCZD), autistic (ASD) and obsessive-
compulsive (OCSD) spectrum disorders is paradigmatic of the current
neuroscientific climate as well as of the difficulties in clinical diagnosis
(Luciano, Keller, Politi, Aguglia, & Magnano, 2014). For instance, some
authors tend to recognize a clear clinical connection between SCZD
and ASD (Bolte, Rudolf, & Poustka, 2002; Hommer & Swedo, 2015;
Nylander, Lugnegård, & Unenge Hallerbäck, 2008; Ornitz, 1969; Rapo-
port, Chavez, Greenstein, Addington, & Gogtay, 2009; Sporn, et al.,
2004; Starling & Dossetor, 2009; Stone & Iguchi, 2011). This idea may
be supported by recent epidemiologic, genetic, molecular, and brain
imaging evidence suggesting an underlying shared neurobiological sub-
strate for ASD and SCZD (Arnone, et al., 2009; Biamino, et al., 2016;
Cheung, et al., 2010; de Lacy & King, 2013; King & Lord, 2011; Stone
& Iguchi, 2011). In turn, it has been hypothesized that a common neu-
robiological mechanism might be at the basis of the repetitive behavior
in both ASD and OCSD (Langen, Durston, Kas, van Engeland, & Staal,
2011a; Langen, Kas, Staal, van Engeland, & Durston, 2011b). Also it has
been proposed that OCSD and SCZD might share similar pathogenetic
underpinnings (Owashi, Ota, Otsubo, Susa, & Kamijima, 2010). Of note,
other brain structural (Goodkind, et al., 2015) and genetic studies (The
Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013;
The Network & Pathway Analysis Subgroup of the Psychiatric
Genomics Consortium, 2015) provide further evidence for transdiag-
nostic overlaps between psychiatric conditions. These findings suggest
significant comorbidities between syndromes as well as relevant over-
lap of their symptomatology (Buckley, Miller, Lehrer, & Castle, 2009;
DeVylder, Burnette, & Yang, 2014; Gorun, et al., 2015; Kessler, et al.,
1994; Markon, 2010; Vaidyanathan, Patrick, & Iacono, 2012).
Therefore, the need to understand brain disorders in terms of neu-
robiological features is ever more compelling (Wang & Krystal, 2014). In
particular, with regard to mental illness it has been proposed that
metabolic and microstructural modifications in certain sets of brain
regions might be associated with many different conditions (Buckholtz &
Meyer-Lindenberg, 2012; Crossley, et al., 2016; Crossley, Scott, Ellison-
Wright, & Mechelli, 2015; Goodkind, et al., 2015; McTeague, Goodkind,
& Etkin, 2016). These abnormalities develop as morphological alterations
of gray matter (GM) or white matter (WM) density, which appear as
increased or decreased values in voxel-based morphometry (VBM) inves-
tigations or as dysfunctional patterns in brain activity (Baker, et al., 2014;
Ellison-Wright & Bullmore, 2010; Etkin & Wager, 2007; Goodkind, et al.,
2015; Hamilton, et al., 2012). These studies challenge the intuitive view
that each and every brain disorder should exhibit a specific pattern of
brain alterations as well as a specific constellation of clinical symptoms
(Buckholtz & Meyer-Lindenberg, 2012; Caspi, et al., 2014; Goodkind,
et al., 2015; McTeague, et al., 2016).
In line with these data a recent study by our research group dem-
onstrated that SCZD, OCSD and ASD do not show distinctive patterns
of GM alterations; rather, these three spectra showed a common pat-
tern, which can be divided into two clusters of alterations extending
across the insulae, medial thalamic and the cingulate cortices (Cauda,
et al., 2017). This finding was also recently supported by a study on
functional alterations (Sprooten, et al., 2017), which has showed that
very few functional differences can be statistically observed in a variety
of psychiatric conditions (i.e., schizophrenia, bipolar disorder, major
depressive disorder, anxiety disorders, and obsessive compulsive disor-
der). Of note, this specific pattern of alterations common to SCZD,
OCSD, and ASD is probably not only shared by these three spectra,
but also by other psychiatric disorders (Buckholtz & Meyer-Lindenberg,
2012; Caspi, et al., 2014; Crossley, et al., 2014; McTeague, et al.,
2016). In fact, it encompasses a set of “core areas” that exhibit higher
functional diversity (Andersson, Kinnison, & Pessoa, 2013; or entropy)
and have been found to be active in a number of important cognitive
functions during fMRI studies (Cauda, et al., 2012b). These core areas
are thought to be part of the salience network (Palaniyappan & Liddle,
2012), which is in turn part of the cognitive control network (Cole &
Schneider, 2007; Niendam, et al., 2012), and are characterized by abun-
dant populations of Von Economo neurons (VEN; Cauda, Geminiani, &
Vercelli, 2014b; Cauda, et al., 2013). VEN are large, spindle-shaped pro-
jection neurons present in layer V of the frontoinsular and cingulate
cortex, supposed to be involved in the pathogenesis of specific neuro-
logical and psychiatric diseases (Cauda, et al., 2014b).
In light of these findings, we devised an innovative meta-analytic
method for performing an anatomical co-alteration networking analysis of
brain disorders. In fact, although this meta-analysis focuses on SCZD, ASD,
and OCSD, our methodology can be generally applied for studying every
disease capable of producing appreciable neuropathological alterations.
In particular, the present study aimed to investigate and address
the following issues:
1. Do neuronal alterations distribute coherently across the brain
areas structurally affected by SCZD, ASD, and OCSD in a network
like manner?
2. In case of a positive answer, can the anatomical co-alteration net-
work of SCZD, ASD, and OCSD be identified?
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3. Within this co-alteration network are there brain areas the altera-
tion of which could lead to a faster and more diffuse distribution
of neuronal abnormalities?
4. Can distinct clusters and/or subclusters of co-altered brain areas
be identified within the co-alteration patterns of neuroanatomical
alterations produced by SCZD, ASD, and OCSD?
5. Finally, can co-altered brain areas exhibit a normal pattern of ana-
tomical covariance? If so, how similar is this pattern to the co-
alteration pattern of the same areas?
2 | MATERIALS AND METHODS
2.1 | Selection of studies
We identified the pool of all eligible experiments in the BrainMap data-
base (www.brainmap.org; Fox & Lancaster, 2002; Laird, et al., 2009;
Laird, et al., 2005) which reported GM/WM changes within the brain
parenchyma. At the time of the selection phase, the BrainMap database
was made up by coordinates and associated meta-data of 3,076 publi-
cations and 15,243 neuroimaging experiments. For the present meta-
analysis, only the brain studies reporting GM and WM changes in
standard stereotaxic space were retrieved. As the first step, we identi-
fied (separately for each spectrum) all experiments that featured at
least one focus of GM or WM change. WM data were not analyzed in
this study but, for the sake of completeness, we reported them in the
tables.
Criteria for including studies in an anatomical likelihood estimation
(ALE) meta-analysis may be influenced by knowledge of the results of
the set of potential studies, leading to inclusion bias. To avoid bias in
location and selection of studies, the following additional measures
were taken: (a) assessment of the bibliographies of each study in Brain-
Map so as to identify additional studies that might have not been
included in the database and (b) search on PubMed of the literature
whose temporal boundaries are not included in the BrainMap database
(https://www.ncbi.nlm.nih.gov/pubmed). With regard to this last step,
a systematic search strategy was used to identify relevant studies, pub-
lished until 15 July 2016, involving SCZD, ASD, and OCSD. The search
algorithm have been constructed so as to match for: “autism spectrum
disorder” (ASD); “obsessive-compulsive disorder” (OCD); “schizophre-
nia”; “schizoaffective disorder”; diffusion tensor imaging (DTI); and
VBM, respectively (for more details on literature search and algorithms,
see the online Supporting Information).
Up until 15 July 2016, 1419 papers had been indexed on PubMed
with the selected search terms. In particular, all the articles were
reviewed in order to ensure: (1) both the presence of the healthy con-
trol group and the pathological sample; (2) that the results were
reported by using the Talairach/Tournoux or Montreal Neurological
Institute (MNI) coordinates; (3) that the foci of interest had a signifi-
cance of at least <.05; (4) that the studies described cerebral structural
changes visible with VBM or DTI (only FA technique); (5) that the stud-
ies were original works; and (6) that original diagnosis was made on the
basis of DSM criteria and clinical test batteries.
We adopted the definition of meta-analysis accepted by the
Cochrane Collaboration (Green, et al., 2008) and the “PRISMA State-
ment” international guidelines in order to ensure a transparent and
complete report of data selection (Liberati, et al., 2009; Moher, Liberati,
Tetzlaff, & Altman, 2009).
Studies from BrainMap database and those from PubMed were
compared looking for cases of multiple references to the same
datasets across articles so as to make sure that only one reference
to the same data contributed to the coordinates for the present
meta-analysis (see Table 1 and Supporting Information, Graph S1).
Then, the studies were examined to detect dissimilarities or discrep-
ancies. The researchers who carried out this research stage have
reached substantial agreement as regards inclusion and exclusion of
studies (Cohen’s K5 .7409).
Meta-data were extracted from each selected article. For all
articles that possessed the information, we evaluated the diagnostic
clusters of each psychiatric spectrum, classifying them on the basis of
what was indicated in the section “Subjects and Methods” by the
authors of the selected articles. In case the authors did not specified
the clinical type described in their study, the “mixed” label was used
(Cauda, et al., 2017). The description of the sample composition and
the distribution of the three psychiatric spectra are viewable on the
online Supplementary Materials. In order to facilitate analysis, coordi-
nates from MNI space were converted into Talairach coordinates by
using Lancaster transformation (Lancaster, et al., 2007).
Given that many experiments do not report GM increased values,
we decided to focus our meta-analysis prevalently on GM decreased
values, performing analysis on 1171 foci of interest (see Table 2). To
have also information about GM increases, their number of foci (which
was not sufficiently large to be statistically analyzed) and the number
of foci associated with GM decreases were summed and analyzed. We
then compared the results of this analysis to those of the analysis per-
formed only on GM decreases data. Since most of our networking anal-
yses principally concern GM decreases data, henceforth we will refer
to the co-alteration network as co-atrophy network. In fact GM
decreased VBM values indicate a volume reduction of neurons, which
can be interpreted as brain atrophy (Table 1).
2.2 | Anatomical likelihood estimation and modeled
activation creation map
We performed an ALE (Eickhoff, Bzdok, Laird, Kurth, & Fox, 2012;
Eickhoff, et al., 2009; Turkeltaub, et al., 2012) to statistically show
the commonalities between the selected experiments on patients with
SCZD, ASD, and OCSD. The ALE is a quantitative voxel-based
meta-analysis technique, which provides information about the
anatomical reliability of results by comparing them with a sample
of reference studies obtained from the existing literature. Each
focus of every study is considered as the central point of a








CAUDA ET AL. | 3
where d is the Euclidean distance between the voxels and the
considered focus, and e is the spatial uncertainty. The standard






For each experiment, we determined a modeled activation (MA)
map, resulting from the union of the Gaussian probability distribution
of every focus of each experiment. Then we determined the ALE map,
derived from the union of the MA maps.
Statistical significance of the activation within the ALE map was
calculated by cluster-level inference, as suggested by Eickhoff et al.
(2012, 2017, 2016). Given a particular cluster forming threshold, a null
distribution of cluster sizes was obtained by simulating a long series of
experiments using the same characteristic of the real data and then by
calculating an ALE map. The obtained score histogram was eventually
used to assign a threshold p values.
TABLE 1 Synopsis of the selection procedure with number of articles identified at each stage











242 1419 44 49 110











Phase 1 Phase 2 Phase 3 Phase 4 Phase 5
+
242 records 1434 records Data
extraction
TABLE 2 White matter and gray matter variations with relative numbers of foci for each of the selected psychiatric spectra. The items shown








* + * +
ASD (N 5 1,719) Mixed form 312 27 66 125 94
Primary autism 186 7 57 93 29
Asperger 54 11 14 2 27
High-functionality autism 53 5 20 16 12
Pervasive developmental
disorder
16 0 11 0 5
OCSD (N 5 1,738) Obsessive-compulsive disorder 364 25 77 67 195
Tourette syndrome 70 13 33 5 19
Trichotillomania 4 0 4 0 0
SCZD (N 5 5,236) Schizophrenia simplex 190 0 4 4 182
Paranoia 20 0 17 1 2
Auditory hallucination 34 7 0 0 27
First episode psychosis 92 3 45 4 40
Mixed form 633 18 160 22 433
First episode schizophrenia 65 5 19 0 41
Acute psychosis with
no hallucination
21 0 21 0 0
Early onset symptoms
of psychosis
52 0 8 0 44
Hallucination 21 0 16 0 5
Paranoia with schizophrenia
symptoms
26 0 9 1 16
Foci (Total) 121 581 340 1,171
702 1,511
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2.3 | Construction of the morphometric co-atrophy
network
In order to identify the distribution of brain alterations we developed an
innovative methodology capable of constructing the anatomical co-
alteration networks of brain disorders. Our analysis can find out
whether or not the structural alteration of brain area A is statistically
concatenated with the alteration of one or more other brain areas (B, C,
etc.). The analysis therefore results in the construction of a morphomet-
ric co-atrophy network (MCN) formed by the brain areas that occur to
be altered together, in which it is possible to examine (i) how an altered
brain area is statistically connected to other altered areas and (ii) which
areas appear to be parts of a more extended web of alterations.
2.4 | Node creation
We created a set of nodes, localized in the points of the ALE map,
derived from the union of the MA maps as described in the previous
section, where the probability of alteration was higher (peaks of ALE
values). In particular, we used a peak detection algorithm to determine
the set of local maxima of the ALE values. We selected the voxels
showing an ALE peak value greater than a given threshold. To avoid an
excessive number of regions of interest (ROIs) a threshold was set at
the 75 percentile of the peak values distribution. We then calculated
the distance between peaks, thus obtaining a distance matrix for each
peak. This was done to avoid ROIs superimposition. Indeed we
excluded all peaks within a distance of 10 mm from other peaks. We
obtained then a definitive set of peaks. Finally, around every peak we
designed a ROI of 10 mm2.
The rationales behind these methodological choices are the follow-
ing. (i) The dimension of the nodes is based on the work of Eickhoff,
et al. (2009) that empirically analyzed meta-analytical imaging data pro-
viding quantitative estimates to explicitly model the spatial uncertainty
associated with the reported coordinate. Since this analysis evidenced
an uncertainty in spatial location with a mean of 10.2 mm with an SD
of .4 mm, we chose a radius of 10 mm for our nodes. (ii) We chose the
75 percentile because if the signal is noisy there is the possibility to
detect false peaks considering the Chebyshev’s inequality (Kotz, Balak-
rishnan, & Johnson, 2000), which shows that, independently of the
type or form of the probability distribution, the proportion of the
observation falling within k standard deviations of the population mean
is at least 12 1k2, which, with k52, correspond to the 75 percentile. (iii)
Although several Authors pointed out that the lack of a gold standard
makes the definition of nodes arbitrary, as shown by Zalesky and col-
leagues (2010) it is possible to make any comparison between net-
works, if the node parcellation was made at the same spatial scale. This
is why we paid particular attention to perform all the analyses at a
comparable spatial scale. For a schema depicting the node detection
pipeline see Figure 1.
2.5 | Co-atrophy distribution and connectivity
To study the co-atrophy pattern, we created a co-alteration matrix
using the previously defined set of nodes. In a N 3 M matrix each row
represents an experiment, while each column represents a network
node; in our particular case the matrix is 127 (experiments) 3 33
(nodes). For each experiment we reported a node (ROI) as being altered
if the experiment MA map reported 20% or more of the voxels within
the ROI.
From this matrix we obtained the strength of the co-alteration
between the nodes by using the Patel’s k index (Patel, Bowman, &
FIGURE 1 Schema depicting the pipeline utilized for the ROI (nodes) detection [Color figure can be viewed at wileyonlinelibrary.com]
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Rilling, 2006). In fact, starting from a Bernoulli generation model of
data it is possible to construct a probability distribution of joint altera-
tion values for each pair of nodes. Given two nodes (a and b), we can
describe their conjoint state of alteration through two binary variables
representing four cases: (i) a and b both altered; (ii) a and b both unal-
tered; (iii) a altered and b unaltered; and (iv) a unaltered and b altered
(Table 3). Therefore, frequencies of the different combinations
through all experiments give the following four probabilities:
u15P a51; b51ð Þ
u25P a51; b50ð Þ
u35P a50; b51ð Þ
u45P a50; b50ð Þ
which represent the conjoint state frequencies of two nodes (a and b)
in all their four possible combinations. Marginal probabilities are illus-
trated by the following table:
Considering these four probabilities, we can apply the two indices
proposed by Patel et al. (2006) for the calculus of connectivity and
directionality, called k and s, respectively. These indices have been vali-
dated by Smith et al. (2011) with simulated data. With regard to Patel’s
s, however, a recent study has criticized its efficacy (Wang, David, Hu,
& Deshpande, 2017). For the sake of caution, we decided therefore to
limit our analysis to the connectivity aspect by solely using Patel’s k
index, even though it is worth noting that the criticism by Wang et al.
is typically directed to problems (i.e., deconvolution of the hemody-
namic response, temporal resolution) related to the application of
empirical Bayesian techniques to fMRI data rather than to anatomical
morphometric data, which are to be considered in the present study.
With regard to Patel’s k, this index measures the probability that
two nodes (say, a and b) appear to be co-altered compared to the prob-
ability that a and b are independently altered. This index is defined as
follows:
j5 #12Eð Þ= D max #1ð Þ2Eð Þ1 12Dð Þ E2min #1ð Þð Þð Þ
where
E5 #11#2ð Þ #11#3ð Þ
max #1ð Þ5min #11#2; #11#3ð Þ
min #1ð Þ5max 0;2#11#21#321ð Þ
In the fraction the numerator represents the difference between the
probability that a and b are co-altered and the expected probability that a
and b are independently altered, whereas the denominator represents a
weighted normalizing constant. Min #1ð Þ indicates the maximum value of
conjoint probability P a; bð Þ, given P að Þ and P bð Þ, while max #1ð Þ indicates
the minimum value of P a; bð Þ, given P að Þ and P bð Þ. Patel’s k index ranges
from 21 and 1. A value of |k| close to 1 is evidence of high connectivity.
The statistical significance of k is evaluated by simulating, through a
Monte Carlo algorithm, a multinomial, generative model of data, which
can take into account alterations of all nodes. In particular, the Monte
Carlo statistical procedure consists in obtaining an estimate of p kjzð Þ by
sampling a Dirichlet distribution and determining the samples’ proportion
in which k > e, where e is the threshold of statistical significance.
2.6 | Topological analysis
Some network-based analysis techniques were employed to analyze
the neural web of co-atrophy area. The network submitted to these
analysis was a connectivity matrix between the previously selected set
of nodes. In this matrix the edges between the nodes are constituted
by the values of the thresholded Patel’s k described in the previous
section. The analysis of complex networks is a powerful technique
for quantifying both brain structure and functional architecture. A
network is defined as a system of nodes connected by a series of
links. In our case the link is the strength of the co-alteration between
nodes.
2.7 | Node degree
The node degree is the number of connections linking a node with
other nodes. We used the degree distribution to compare the node
degree of different networks. By using the degree distribution we com-
pared a randomly generated network with those exhibited by the three
psychiatric spectra. The degree distribution is the fraction of nodes
with degree k, which is defined as:
PðkÞ5 nk
n
2.8 | Edge betweenness
The edge betweenness consists in the number of the shortest paths
going through an edge within a graph or a network (Girvan & Newman,
2002). Edges with high values of betweenness are involved in a large
number of shortest paths, so that their removal may affect communica-
tion between many pairs of nodes.
2.9 | Network clustering
We employed the k-core decomposition algorithm (Alvarez-Hamelin,
Dall’asta, Barrat, & Vespignani, 2005; Bader & Hogue, 2003) to disen-
tangle the hierarchical structures of our concordance network by pro-
gressively focusing on their central cores. A k-core of a graph G is the
highest connected subgraph of G, in which all the vertices (at least)
present a degree of k. In fact, the k-core decomposition of a network
recursively removes all the vertices having a degree less than k, until in
the graph all vertices with degree k or more remain. This procedure
allowed us to consider our concordance network graph as the central
most densely cluster or connected subgraph.




Voxel b Altered u1 u3 u11u3
Unaltered u2 u4 u21u4
u11u2 u31u4 1
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2.10 | Anatomical dataset (normative population)
2.10.1 | Subjects and image acquisition
For the anatomical covariance we employed the Beijing dataset which
has been publicly released within the “1000 Functional Connectomes”
Project. This dataset consists of 198 subjects (76 males and 122
female) with age ranging from 18 to 26 years, mean 21.16, SD 1.83,
that underwent structural and resting-state scans. All subjects were
right-handed and had no history of neurological or psychiatric disor-
ders. Written informed consent was obtained from each participant,
and the study was approved by the Institutional Review Board of Bei-
jing Normal University Imaging Center for Brain Research.
MRI data were acquired using a SIEMENS TRIO 3-Tesla scanner in
the Beijing Normal University Imaging Center for Brain Research. Par-
ticipants lay supine with the head fixed by straps and foam pads so as
to minimize movements. During the resting-state session, participants
were instructed to be as still as possible and let their mind roam. Func-
tional images were obtained using an EPI sequence with the following
parameters: 33 axial slices, thickness/gap53/.6 mm, in-plane
resolution564 3 64, TR52,000 ms, TE530 ms, flip angle5908,
FOV5200 3 200 mm. Furthermore, a T1-weighted sagittal three-
dimensional magnetization-prepared rapid gradient echo (MPRAGE)
sequence was acquired, which covered the entire brain: 128 slices,
TR52,530 ms, TE53.39 ms, slice thickness51.33 mm, flip angle5
78, inversion time51,100 ms, FOV5256 3 256 mm, and in-plane
resolution5256 3 192.
2.10.2 | Structural covariance analysis on normative
population
The structural covariance analysis was conducted on the anatomical
dataset of normative population previously described with an opti-
mized protocol using the FSL Tools (Douaud, et al., 2007; Good, et al.,
2001; Smith, et al., 2004). First, structural images were brain-extracted
and GM-segmented before being registered to the MNI 152 standard
space using non-linear registration (Andersson, Jenkinson, & Smith,
2007). The obtained images were averaged and flipped along the x-axis
to create a left-right symmetric, study-specific GM template. Second,
all native GM images were non-linearly registered to this study-specific
template and “modulated” to correct for local expansion (or contrac-
tion) due to the non-linear component of the spatial transformation
(Good, et al., 2001). The modulated GM images were then smoothed
with an isotropic Gaussian kernel with a sigma of 3 mm (Andersson,
et al., 2007; Douaud, et al., 2007; Good, et al., 2001; Smith, et al.,
2004). The GM images were also merged to obtain a 4D image: the
usual x, y, and z coordinates of the brain standard space (MNI coordi-
nates) and along the 4th dimension of the various subjects. For the
node coordinates obtained from the ALE analysis we extracted a set of
time series to form a matrix of dimension subjects 3 nodes. To do so,
for each ROI we averaged the time courses of all voxel belonging to
this ROI. From this matrix we calculated the correlation between
the columns, thus obtaining a correlation matrix of dimension
nodes 3 nodes. The correlation matrix was compared with the co-
alteration matrix using a BRAMILA tool to perform a Mantel test
(Glerean, et al., 2016; Mantel, 1967). This procedure is a type of ran-
domization in which the columns of the matrices are permutated and
the correlation between the distances is consequently calculated
(5,000 times).
2.11 | Reliability
To better understand the contribution of each spectrum to the MCN
we tried to determine the co-alteration patterns associated with each
spectrum. However, the number of experiments of two spectra (ASD
and OCSD) was not sufficient for a valid statistical analysis; indeed the
statistics on ASD or OCSD data only did not produce any significant
results. We therefore decided to conduct four different analyses. (1)
One spectrum was left out in alternation to study how its removal
could change the MCN. (2) We statistically compared (correlation) the
Patel’s k values of each edge between the three spectra. (3) We created
a Euclidean distance matrix between the MA maps obtained from all
the three spectra and performed a k-mean clustering of the same maps
to visualize the different contributions of experiments to the MCN (see
Supporting Information for methodological details). (4) To further inves-
tigate the possibility that the greater amount of SCZD data could
somehow drive our results, we constructed the MCN with an equal
number of experiments for each spectrum. We did not adopt this pro-
cedure in the main analysis because we wanted to use as much data as
possible for statistical needs. Inevitably, a single sampling, with the
inclusion of some SCZD data and the exclusion of others, would have
produced biased and less representative results. To avoid this issue we
used a bootstrap technique by randomly selecting a number of SCZD
experiments (from 25 to 30 studies; this interval corresponds to the
sample range of ASD and OCSD) that was equal to the average of the
number of experiments about ASD and OCSD. We then constructed
the co-alteration matrix for this whole new dataset (for more details
see Section 2). This type of analysis was repeated with 1,000 permuta-
tions (each time by selecting a different sample from SCZD data), so as
to assess the stability of the results (SE). We subsequently evaluated
with the Dice coefficient (DC) the overlapping value between the aver-
aged MCN obtained with this new analysis and the MCN obtained
with the whole original dataset. By comparing two samples (in our case





where jXj and jYj are the number of elements of the two samples,
respectively.
3 | RESULTS
3.1 | Common patterns of anatomical alterations
We performed an ALE that pooled the outcomes of all the experiments
taken into consideration in this meta-analysis. This statistic analysis
revealed significant GM density decreased values mainly in the dorsal
lateral prefrontal cortex, insulae, medial thalami, ventromedial
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prefrontal, orbitofrontal, precentral, and cingulate areas. In contrast,
GM density increased values were found mainly in frontal poles, poste-
rior lateral thalami, caudate nuclei, putamen, posterior parietal, cerebel-
lar and inferior temporal cortices (Figure 2).
3.2 | Co-atrophy network
Our meta-analysis prevalently focuses on GM decreased values, as
many experiments do not report GM increased values.
The left panel of Figure 3 and Table 4 show the regions of interest
forming the MCN, while the right panel of Figure 3 illustrates the dis-
tance matrix showing the k values between nodes. In turn, Figure 4
illustrates the MCN: edges colored from blue to red indicate increasing
k values.
The node creation reported 33 nodes placed in prefrontal, insular,
cingulate, hippocampal, lateral and medial parietal, temporal and
thalamic brain areas. Eight nodes out of 33 were found to be uncon-
nected (i.e., they do not exhibit any significant edge of co-atrophy).
The co-atrophy network, as evidenced in Table 5 and Figure 4, shows
70 edges, among which the 20 ones with the highest Patel’s k values (i.e.,
the couples of most strongly co-altered nodes) are shown in Figure 6.
Most of them involves insulo-frontal, insulo-insular, insulo-hippocampal
and frontoparietal co-altered nodes. Patel’s k values range from .92 of the
insular and fronto-orbital edges to .37 of the insulo-supplementary motor
areas’ edges (see the k value graph of S4 in Supporting Information).
Figure 5 shows a representation of the MCN in which the nodes
are characterized by sizes and colors proportionally to their degree val-
ues. In other words, according to their low or high degree values, nodes
are proportionally represented in small or big sizes and in green or red
colors. Among the nodes the insular cortices and inferior frontal areas
show the highest degree values, followed by the superior temporal,
thalamic, parahippocampal, precentral hippocampal and cingulate
FIGURE 3 The left panels shows the nodes that entered the co-atrophy calculation. The right panel shows the co-atrophy matrix. Colors
from blue to red indicates increasing Patel’s k values (i.e., increasing co-alteration probabilities [Color figure can be viewed at wileyonlineli-
brary.com]
FIGURE 2 Gray matter anatomical likelihood estimation (ALE) results. The image summarizes the results of all the experiments considered
in this meta-analysis. Colors from red to yellow show gray matter increases, colors from blue to green show gray matter decreases (ALE
maps were computed at a threshold of p < .001, cluster-level corrected for multiple comparison (Eickhoff et al., 2016) and visualized using
BrainVoyager QX. Only decreases have been utilized for the subsequent analysis [Color figure can be viewed at wileyonlinelibrary.com]
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regions. Node degree values range from 1 to 8, while node between-
ness values range from 0 to .15. Co-alterations between nodes exhibit
a network-like pattern because the connectivity matrix is obtained
using the Patel’s k, which is calculated by means of a Monte Carlo sim-
ulation based on the conjoint probability distribution of altered and
unaltered nodes. Indeed in this procedure, the null hypothesis is that
no network-like architecture is present, which is to say that all
connections are casual or random. Figure 6 shows the 20 edges with
the highest Patel’s k values (i.e., the couples of most strongly co-altered
nodes).
As the MCN is rather large, we investigated the possibility of
identifying within it the central most densely connected subnet-
works. The analysis conducted with the k-core decomposition algo-
rithm reported a subnetwork (shown in Figure 7) composed of
eleven nodes located in the insulae, inferior frontal gyrus (IFG),
superior temporal gyrus (STG), thalamus and right precentral gyrus.
Similarly to Figure 5, Figure 7 right panel shows the node degree
and the edge betweenness. Node degree values range from 1 to 8,
while node betweenness values range from 2.5 to 4.5. Low or high
degree values of nodes are proportionally represented in small or big
sizes and in green or red colors. In addition, edges with low or high
betweenness are represented in green or red colors and proportion-
ally vary in thickness. Although the nodes exhibiting the highest
degree are the insular and inferior frontal areas, the connections
showing the highest values of edge betweenness link the insular and
precentral/thalamic regions (Figure 7, right panel).
Since several ROIs fall within the insular cortices (Figure 8, upper
panel), in order to inspect the pattern of connectivity of these nodes
we calculated for each of them the resting state functional connectivity
(see Supporting Information for a brief description of the connectivity
methods). We found that the five different insular nodes express three
different patterns of connectivity (Figure 8, middle panel): one sensori-
motor (Insula_R2), three ventral attentional (Insula_R, Insula_R1, Insu-
la_L1), and one showing part of the default mode network (DMN)
(Insula_L). The attentional nodes are all placed in the anterior insulae
and the sensorimotor one in the right posterior insula. The DMN one is
also the most ventral among the five. The two nodes characterized by
a ventral attentional connectivity pattern are located in the most ante-
rior dorsal regions. The lower panel of Figure 8 shows the network
composed by the first connected nodes of these three different pat-
terns (Insula_R2; Insula_R, Insula_R1, Insula_L1; Insula_L). All the three
patterns show interconnections between insular ROIs; aside from these
insular connections, Insula_R2 is connected with superior frontal gyrus
and the supplementary motor area.
3.3 | Structural covariance analysis
The structural co-atrophy/co-alteration data can be considered a form
of pathological anatomical structural covariance. To better compare the
normal structural covariance and the pathological alteration of the
nodes that, within the MCN, appear to be the most frequently charac-
terized by GM reduction, we calculated the former in a normative pop-
ulation constituted by a set of healthy subjects. Figure 9 (upper panels)
shows the results of this analysis. The investigated nodes exhibit a rich
pattern of anatomical covariance that is fairly correlated with the co-
atrophy pattern (r5 .2059). This value is statistically significant
(p < .0076). The anatomical covariance edges have r values ranging
from .67 to .31 (Table 6). The 20 edges with the highest covariance val-
ues are shown in Figure 10 and mostly exhibit fronto-parietal, insulo-
frontal, insulo-parietal and temporo-frontal correlations. The nodes
TABLE 4 Nodes employed for the co-atrophy analysis
Tal Coord
Node Name X Y Z
Cingulum_Ant_R 6 20 28
Cingulum_Mid_L 28 216 44
Frontal_Inf_Oper_L 250 10 16
Frontal_Inf_Oper_R 42 10 8
Frontal_Inf_Orb_L 238 24 24
Frontal_Inf_Tri_R 50 16 20
Frontal_Mid_L 236 42 20
Frontal_Mid_Orb_L 232 54 24
Frontal_Mid_R 42 38 14
Frontal_Sup_Medial_L 22 56 18
Frontal_Sup_Medial_L_1 22 28 40
Hippocampus_L 218 210 216
Insula_L 238 16 210
Insula_L_1 242 14 0
Insula_R 42 8 22
Insula_R_1 42 18 0
Insula_R_2 34 24 10
Lingual_L 232 288 216
Lingual_L_1 212 244 24
ParaHippocampal_L 222 2 226
ParaHippocampal_R 22 218 212
Parietal_Inf_L 246 256 44
Parietal_Inf_L_1 234 242 44
Precentral_R 46 4 32
Precuneus_R 18 258 14
Precuneus_R_1 18 266 26
Precuneus_R_2 8 264 54
Supp_Motor_Area_L 0 4 46
SupraMarginal_L 260 252 28
Temporal_Mid_L 246 264 4
Temporal_Sup_L 252 210 4
Temporal_Sup_L_1 250 220 12
Thalamus_L 22 220 4
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with the highest degree are localized in medial and inferior frontal cor-
tices, right insula, right precuneus and left supramarginal cortices (Fig-
ure 11, left panel).
Areas showing both anatomical covariance and co-atrophy (AND
logic between anatomical covariance and co-atrophy values; see Figure
9 lower panels, Figure 11 right panel for comparison between edges)
mainly exhibit insulo-insular, interemispheric, fronto-insular, cingulo-
insular and insulo-temporal connections, all of which are present both
in the anatomical covariance and in the pathological co-atrophy analy-
ses. Among the nodes showing both anatomical covariance and patho-
logical co-atrophy, the ones with the highest degree are those placed
in orbitofrontal, opercular and insular regions (Figure 11, right panel).
Edges showing the highest edge betweenness values are those linking
fronto-insular and temporo-insular nodes (Figure 11, right panel).
3.4 | Co-alteration networks of GM decreases and GM
increases
As already said, most of the studies examined in this meta-analysis do
not report GM increase data. However, since we wanted to obtain
information from these data as well, we performed a co-alteration anal-
ysis on a dataset that was the sum of GM decreased and increased val-
ues. The rationale for doing this was that GM increase data were not
on their own sufficient to be statistically examined.
Specifically, we conducted two supplementary analyses using as
inputs both GM decrease and GM increase data. In the first analysis
we employed the same set of nodes previously used for the MCN (see
Figure 12, left panel, Table 4). In the second analysis we created a new
set of nodes keeping the same node detection parameters already
employed.
The first analysis of data (GM decrease plus GM increase) with the
same set of nodes of the MCN shows a co-alteration pattern that is
somewhat similar to the pattern obtained from the analysis of GM
decrease data only (Figure 12, right and middle panels). It can be
observed that in both analyses the group of main edges linking the
insular, cingulate, temporal and parietal cortices is quite constant, even
though it is slightly thicker when the sum of GM decrease and GM
increase is considered. However, some prefrontal and parietal connec-
tions, which are only present when GM decrease data are considered,
are lost. In the results obtained from both GM decrease and GM
increase data, Patel’s k values range from .93 to .34.
The second analysis of data (GM decrease plus GM increase), con-
ducted with a new set of nodes, shows a much thicker network (Figure
12, left panel). New nodes, which were not present in the results
obtained from GM decrease data only, now emerge, while the nodes
that were lost in the first analysis return to be part of the network.
Also in this case Patel’s k values range from .93 to .34.
Figure 13 upper panels show the pattern of anatomical covariance
in healthy subjects associated with the new set of nodes used in the
second analysis of data (GM decrease plus GM increase); Figure 13
lower panels show the comparison between the co-alteration pattern
obtained from both GM decrease and GM increase data and the ana-
tomical covariance of the same nodes in healthy subjects. In the case
of the new set of nodes r values range from .25 to .78; while in the
case of the previous set of nodes r values range from .34 to .93.
Just at first sight it is evident that the pattern of anatomical covari-
ance and the co-alteration pattern are less similar when GM decrease and
GM increase data are analyzed together than when only GM decrease
data are analyzed. In fact in this case the correlation value is r5 .1452
FIGURE 4 Morphometric co-atrophy network results. Colors from blue to red indicates increasing Patel’s k values (i.e., increasing co-
alteration probabilities) [Color figure can be viewed at wileyonlinelibrary.com]
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TABLE 5 Edge anatomical co-atrophy strength between co-altered nodes (Patel’s k)
X Y Z Node 1 X Y Z Node 2 Patel’s k
218 210 216 Hippocampus_L 22 218 212 ParaHippocampal_R .4574
222 2 226 ParaHippocampal_L 238 16 210 Insula_L .4439
218 210 216 Hippocampus_L 238 16 210 Insula_L .5129
222 2 226 ParaHippocampal_L 238 24 24 Frontal_Inf_Orb_L .5516
218 210 216 Hippocampus_L 238 24 24 Frontal_Inf_Orb_L .4961
238 16 210 Insula_L 238 24 24 Frontal_Inf_Orb_L .7499
222 2 226 ParaHippocampal_L 42 8 22 Insula_R .8412
218 210 216 Hippocampus_L 42 8 22 Insula_R .4695
238 16 210 Insula_L 42 8 22 Insula_R .6024
238 24 24 Frontal_Inf_Orb_L 42 8 22 Insula_R .6568
222 2 226 ParaHippocampal_L 242 14 0 Insula_L_1 .5438
238 16 210 Insula_L 242 14 0 Insula_L_1 .8574
238 24 24 Frontal_Inf_Orb_L 242 14 0 Insula_L_1 .7781
42 8 22 Insula_R 242 14 0 Insula_L_1 .6787
222 2 226 ParaHippocampal_L 42 18 0 Insula_R_1 .6509
238 16 210 Insula_L 42 18 0 Insula_R_1 .7408
238 24 24 Frontal_Inf_Orb_L 42 18 0 Insula_R_1 .7202
42 8 22 Insula_R 42 18 0 Insula_R_1 .884
242 14 0 Insula_L_1 42 18 0 Insula_R_1 .7877
222 2 226 ParaHippocampal_L 246 264 4 Temporal_Mid_L .706
238 16 210 Insula_L 22 220 4 Thalamus_L .4655
42 8 22 Insula_R 22 220 4 Thalamus_L .4183
242 14 0 Insula_L_1 22 220 4 Thalamus_L .5438
42 18 0 Insula_R_1 22 220 4 Thalamus_L .6326
246 264 4 Temporal_Mid_L 22 220 4 Thalamus_L .6959
218 210 216 Hippocampus_L 252 210 4 Temporal_Sup_L .4574
238 16 210 Insula_L 252 210 4 Temporal_Sup_L .5666
238 24 24 Frontal_Inf_Orb_L 252 210 4 Temporal_Sup_L .8068
42 8 22 Insula_R 252 210 4 Temporal_Sup_L .5277
242 14 0 Insula_L_1 252 210 4 Temporal_Sup_L .5438
42 18 0 Insula_R_1 252 210 4 Temporal_Sup_L .5358
222 2 226 ParaHippocampal_L 42 10 8 Frontal_Inf_Oper_R .6509
238 16 210 Insula_L 42 10 8 Frontal_Inf_Oper_R .6775
238 24 24 Frontal_Inf_Orb_L 42 10 8 Frontal_Inf_Oper_R .6628
42 8 22 Insula_R 42 10 8 Frontal_Inf_Oper_R .8412
242 14 0 Insula_L_1 42 10 8 Frontal_Inf_Oper_R .7877
42 18 0 Insula_R_1 42 10 8 Frontal_Inf_Oper_R .926
22 220 4 Thalamus_L 42 10 8 Frontal_Inf_Oper_R .6326
42 8 22 Insula_R 34 24 10 Insula_R_2 .4183
(Continues)
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(p < .0347). This is probably so because the new nodes obtained by add-
ing the GM increase data are more anatomically covariant than anatomi-
cally co-altered. The nodes and edges shared by the anatomical
covariance matrix and the matrix obtained from both GM decrease and
GM increase data are those associated with the connections between the
insular cortices and between the insular and prefrontal/cingulate cortices
already found in the MCN. In addition to these connections, other ones
occur between the cingulate and posterior parietal cortices. Therefore,
similarities between the anatomical covariance matrix and the matrix
obtained from both GM decrease and GM increase are less statistically
relevant, but they extend beyond the insular cortices, involving also
prefrontal, cingulate and parietal regions, which are not present when the
anatomical covariance matrix and theMCNmatrix are compared.
3.5 | Reliability
Analysis 1 reveals that certain edges linking the insulae, temporal lobes
and cingulate cortices are always present in the MCN, independently
of which spectrum is removed. These edges connect the “core” areas
already described in Cauda, et al. (2017). Most of the other edges are
present when ASD and OCSD are removed, but not when SCZD is left
out of the analysis. In this case, the MCN is significantly less distributed
TABLE 5 (Continued)
X Y Z Node 1 X Y Z Node 2 Patel’s k
238 16 210 Insula_L 250 220 12 Temporal_Sup_L_1 .5666
238 24 24 Frontal_Inf_Orb_L 250 220 12 Temporal_Sup_L_1 .6629
42 8 22 Insula_R 250 220 12 Temporal_Sup_L_1 .5277
242 14 0 Insula_L_1 250 220 12 Temporal_Sup_L_1 .5438
42 18 0 Insula_R_1 250 220 12 Temporal_Sup_L_1 .5358
252 210 4 Temporal_Sup_L 250 220 12 Temporal_Sup_L_1 .4662
242 14 0 Insula_L_1 250 10 16 Frontal_Inf_Oper_L .4874
250 220 12 Temporal_Sup_L_1 250 10 16 Frontal_Inf_Oper_L .4883
222 2 226 ParaHippocampal_L 50 16 20 Frontal_Inf_Tri_R .413
246 264 4 Temporal_Mid_L 50 16 20 Frontal_Inf_Tri_R .7108
42 10 8 Frontal_Inf_Oper_R 50 16 20 Frontal_Inf_Tri_R .4654
250 220 12 Temporal_Sup_L_1 50 16 20 Frontal_Inf_Tri_R .413
238 16 210 Insula_L 6 20 28 Cingulum_Ant_R .4807
42 8 22 Insula_R 6 20 28 Cingulum_Ant_R .6127
42 18 0 Insula_R_1 6 20 28 Cingulum_Ant_R .6194
42 10 8 Frontal_Inf_Oper_R 6 20 28 Cingulum_Ant_R .6194
250 220 12 Temporal_Sup_L_1 6 20 28 Cingulum_Ant_R .5301
18 258 14 Precuneus_R 6 20 28 Cingulum_Ant_R .6271
238 16 210 Insula_L 46 4 32 Precentral_R .5005
242 14 0 Insula_L_1 46 4 32 Precentral_R .4744
42 18 0 Insula_R_1 46 4 32 Precentral_R .4654
22 220 4 Thalamus_L 46 4 32 Precentral_R .5329
42 10 8 Frontal_Inf_Oper_R 46 4 32 Precentral_R .4654
50 16 20 Frontal_Inf_Tri_R 46 4 32 Precentral_R .4225
250 10 16 Frontal_Inf_Oper_L 234 242 44 Parietal_Inf_L_1 .6016
42 8 22 Insula_R 0 4 46 Supp_Motor_Area_L .3729
34 24 10 Insula_R_2 0 4 46 Supp_Motor_Area_L .3835
250 10 16 Frontal_Inf_Oper_L 0 4 46 Supp_Motor_Area_L .5369
18 266 26 Precuneus_R_1 0 4 46 Supp_Motor_Area_L .5881
234 242 44 Parietal_Inf_L_1 0 4 46 Supp_Motor_Area_L .5881
212 244 24 Lingual_L_1 8 264 54 Precuneus_R_2 .5359
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and less relevant edges are present (see also Supporting Information,
Figure S7).
This phenomenon can be better understood in light of analysis 2,
which reveals that the correlation results between the Patel’s k values
of the edges associated to each spectrum suggest a good similarity
between ASD and SCZD, and between OCSD and SCZD: for ASD
versus SCZD r5 .37, and for OCSD versus SCZD r5 .56, respectively.
In contrast, correlation values between the ASD matrix and OCSD
matrix appear to be less similar: for ASD versus OCSD r5 .13.
As already pointed out in Cauda, et al. (2017), analysis 3 reveals
that the structural alterations (GM decreases) caused by the three
spectra can be clearly subsumed under two clusters. Neither of the
two clusters can be specifically associated with a spectrum, as all three
psychiatric disorders distribute almost equally within them (see Sup-
porting Information, Figure S3). Figure 14 summarizes the results of
these three analyses.
As Figure 14 illustrates, when we leave SCZD out, the number of
edges substantially diminishes; this, along with the fact that ASD and
OCSD have more inhomogeneous sample data, as shown in Cauda
et al. (2017), explains why the correlation value between the matrix
constructed with the SCZD data only and the matrix constructed with
the whole dataset is low. Moreover, it is worth noting that, even
though results are significantly reduced when SCZD is left out, the
remaining edges are those that form the most connected part of the
MCN, which is also the core of the pattern constructed with the SCZD
data only (please see both the upper right panel of Figure 14 and the
upper panel of Supporting Information, Figure S5).
Finally, analysis 4 shows a high degree of similarity between the
MCN constructed with the same amount of data for each spectrum
and the MCN constructed with the original dataset. In fact, the DC is
significantly high: .7969 (Figure 15, left and middle panels). Moreover,
the evaluation of the stability of the result has been assessed by
repeating the analysis with 1,000 permutations (each time with a differ-
ent sample selection from SCZD data). Of note, the standard error has
very low values, ranging from 0 to .04 (Figure 15, right panel). The
result of analysis 4 shows that, even though the reduced sample leads
to the loss of certain edges and the decrease of Patel’s k values, the
new MCN largely overlaps the original MCN obtained with the whole
FIGURE 5 Topological analysis of the morphometric co-atrophy
network. Colors and dimensions of nodes indicates their topological
degree (smaller node5 lower degree; from green to red5 from
lower to higher values) [Color figure can be viewed at wileyonlineli-
brary.com]
FIGURE 6 Morphometric co-atrophy network results. This graph shows the 20 edges showing the highest Patel’s k values (i.e., the couples
of most strongly co-altered nodes) [Color figure can be viewed at wileyonlinelibrary.com]
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dataset, thus providing evidence that the predominance of SCZD data
does not bias the validity of our original outcome.
4 | DISCUSSION
The analysis of the co-atrophy network of SCZD, ASD, and OCSD
reveals that alterations in certain GM sites appear to be statistically
related to alterations of other GM regions. Although this finding has
already been proved to be the case in neurodegenerative diseases, it
has never been found before in psychiatric conditions. As our study
dealt mainly with GM decreases, we propose to define the ensemble
of co-altered areas as morphometric co-atrophy network or MCN and
the structural and functional pathways linking these areas as
pathoconnectivity.
Our analysis of VBM data has revealed that alterations in the GM
density of patients with SCZD, ASD, and OCSD do not develop ran-
domly but rather follow identifiable patterns of co-alteration. In partic-
ular, our results indicate that a small number of brain areas show a high
degree of pathoconnectivity (Yates, 2012); in other words, only a few
cerebral areas appear to be particularly co-altered with several other
regions. Many of these areas also exhibit a normal pattern of anatomi-
cal covariance that can be partly altered by the progressive impact of
SCZD, ASD, and OCSD. Clearly, these brain sites play an important
role in the formation and development of the MCN and, as a conse-
quence, can be thought of as pathoconnectivity hubs. For instance, the
left lingual gyrus appears to be co-altered only with one particular area
(i.e., the right precuneus), whereas the left insula (ROI Insula_L1)
appears to be co-altered with eleven other regions. Thus, the co-
alteration patterns of these two areas contribute differently in shaping
and developing the MCN across the brain. In fact, neuronal alterations
are supposed to distribute more quickly and diffusely from cerebral
regions showing a high degree of pathoconnectivity. These results
were obtained by calculating the network degree or level of connectiv-
ity for each altered area.
Overall, brain sites with the highest network degree were found to
be the insulae and the prefrontal cortices, which are also densely con-
nected with each other. These regions are therefore pathoconnectivity
hubs and can be considered as primary altered areas, whereas the other
brain regions, which have a lower network degree and appear to be
connected only with pathoconnectivity hubs, can be considered as sec-
ondary altered areas.
The network clustering analysis developed and employed in this
study was able to identify within the MCN a “core” subnetwork com-
posed of eleven nodes located in the insulae, IFG, STG, thalamus, and
right precentral gyrus. Some of these regions are involved in supporting
the salience network, which is an essential part of the frontoparietal
control system. The insular cortices are pivotal components of this
important circuitry, which has been found to be altered in a great vari-
ety of brain disorders (Cole, Repovs, & Anticevic, 2014; McTeague,
et al., 2016; Sprooten, et al., 2017). In particular, the disruption of the
functional integrity of this network would account for the executive
deficits that are frequently observed across several psychiatric
FIGURE 7 Network clustering. On the basis of our data, the k-core algorithm reported a subnetworks evidenced in the left panel (yellow
nodes) and in the right panel. Colors and dimensions of nodes indicates their topological degree (smaller node5 lower degree; from green
to red5 from lower to higher values). Colors and dimensions of edges indicates the degree of edge betweenness (smaller edge5 lower
degree; from green to red5 from lower to higher values) [Color figure can be viewed at wileyonlinelibrary.com]
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conditions (Power, et al., 2011). That the insula might be thought of as
a pathoconnectivity hub is not surprising, as this brain area has vast
and extensive connections to both several cortical areas and the limbic
system. The insula has also been found to be involved in important
brain functions—that is, integration of external sensory stimuli with
emotions, the conscious perception of error, the generation and main-
tenance of a state of awareness associated with the body’s condition
(Cauda, et al., 2012a; Cauda, et al., 2011a; Klein, Ullsperger, & Daniel-
meier, 2013; Vercelli, et al., 2016; Wylie & Tregellas, 2010).
Our analysis reveals that particularly the anterior part of the insular
cortex seems to be mostly involved in the formation of the MCN asso-
ciated with SCZD, ASD, and OCSD. In fact only one node was located
within the posterior insula (i.e., Insula_R2). This node has been found to
be part of a network with sensorimotor functions. Overall, these find-
ings provide evidence that the insula is not only an important brain hub
supporting functional connectivity during rest as well as task activities,
but also a pathoconnectivity hub lying at the center of co-alteration
networks produced by a variety of brain disorders. Indeed the idea that
anatomically defined subsets of brain regions might be hotspots for
abnormality of GM volume is supported by the fact that these core
areas are more functionally valuable for higher-order cognitive tasks
and adaptive behavior, and thereby also more likely to be associated
with a wide range of pathological processes (Crossley, et al., 2016;
Crossley, et al., 2014).
The STG multimodal areas are involved in cortical integration of
both sensory and limbic information at the highest level; this makes
them key regions implicated in the social perceptual skills. Moreover,
STG is thought to process biological motion (Jou, et al., 2011a; Jou,
et al., 2011b) and has been associated with some verbal and non-
verbal communication impairments observed in patients with ASD
(Radua, Via, Catani, & Mataix-Cols, 2011).
Precentral and inferior frontal gyri are involved in the mirror neu-
ron system; GM thinning in regions associated with the mirror-neuron
system have been correlated with social and communication deficits in
patients with ASD (Cattaneo & Rizzolatti, 2009; Keller, Bugiani, Fantin,
& Pirfo, 2011; Kilner, Friston, & Frith, 2007; Rizzolatti & Craighero,
2004).
The disruption of the thalamus has been variously associated with
SCZD and ASD. For instance, a reduced GM density in the thalamus,
right cerebellum hemisphere and left temporoparietal cortex is related
to intellectual disabilities in ASD (Spencer, et al., 2006). Moreover,
other findings suggest a relationship between hypoconnectivity
FIGURE 8 The upper panel shows the location of the insular nodes. The middle panel shows the meta-analytic connectivity modeling
(MACM) associated to these nodes (p < .001 cluster-level corrected for multiple comparison). Nodes are associated on the basis of their
patterns of connectivity. The lower panel shows the first-step nodes of the morphometric co-atrophy network connected to the insular
nodes pertaining to each connectivity pattern [Color figure can be viewed at wileyonlinelibrary.com]
CAUDA ET AL. | 15
disturbances in the thalamofrontal system and ASD (Cheon, et al.,
2011). As we will see, the thalamus is also supposed to play an impor-
tant role in inflammatory processes.
It is worth noting that the brain areas altered by the three spectra
(the nodes of our analyses) have a normal pattern of anatomical covari-
ance (Evans, 2013). This pattern overlaps partially with the MCN
(r5 .2059, p < .0076). Similarities are mainly found in the insulo-insular
as well as cingulo-cingulate intraparietal connections. This result sug-
gests that the normal anatomical covariance of insular and cingulate
areas tends to be progressively altered toward the development of a
pathological anatomical covariance (co-atrophy). Our finding is in line
with the frequent observation that the patterns of brain co-alterations
match in part the patterns of brain connectivity (Cauda, et al., 2017;
Cauda, et al., 2012b; Crossley, et al., 2016; Crossley, et al., 2014; Evans,
2013; Fornito, et al., 2015; Menon, 2013; Raj, et al., 2012; Saxena &
Caroni, 2011; Seeley, et al., 2009; Yates, 2012; Zhou, et al., 2012). In
contrast, when different edges are involved, as it is the case of the
other altered or co-atrophic areas of the MCN, especially those with a
lower network degree, the normal pattern of anatomical covariance
does not overlap with the alteration pattern.
The fact that neuronal abnormalities caused by SCZD, ASD, and
OCSD converge on a set of core areas that are associated with cogni-
tive control functions (Buckholtz & Meyer-Lindenberg, 2012;
McTeague, et al., 2016) is also consistent with previous evidence show-
ing that in brain disorders GM alterations and WM alterations tend to
exhibit concordant patterns of distribution, which are influenced by
brain connectivity (Iturria-Medina & Evans, 2015; Raj, et al., 2012; Voy-
tek & Knight, 2015; Zhou, et al., 2012). As already pointed out, this
FIGURE 9 Anatomical covariance results. The upper left panels shows the structural covariance network results for the same set of nodes
employed in the co-atrophy analysis. The upper right panel shows the anatomical covariance matrix. The lower left panels shows the logic
AND between the co-atrophy results and the structural covariance network results for the same set of nodes employed in the co-atrophy
analysis (i.e., the edges represented are those that are statistically significant in the co-atrophy AND in the anatomical covariance analysis).
The lower right panel shows the logic AND between the anatomical covariance matrix and the co-atrophy co-alteration matrix. The
correlation between the two matrices is .2059 (p < .0076). Colors from blue to red indicates increasing correlation values (r) [Color figure
can be viewed at wileyonlinelibrary.com]
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TABLE 6 Edge anatomical covariance strength between nodes (r)
X Y Z Node 1 X Y Z Node 2 r
42 38 14 Frontal_Mid_R 212 244 24 Lingual_L_1 .6716
42 38 14 Frontal_Mid_R 42 10 8 Frontal_Inf_Oper_R .668
236 42 20 Frontal_Mid_L 18 258 14 Precuneus_R .6495
42 18 0 Insula_R_1 238 24 24 Frontal_Inf_Orb_L .6493
250 10 16 Frontal_Inf_Oper_L 252 210 4 Temporal_Sup_L .6463
18 258 14 Precuneus_R 42 10 8 Frontal_Inf_Oper_R .6324
42 18 0 Insula_R_1 42 8 22 Insula_R .6321
42 10 8 Frontal_Inf_Oper_R 212 244 24 Lingual_L_1 .6264
42 8 22 Insula_R 238 24 24 Frontal_Inf_Orb_L .6258
42 8 22 Insula_R 232 54 24 Frontal_Mid_Orb_L .6253
22 220 4 Thalamus_L 242 14 0 Insula_L_1 .6189
18 266 26 Precuneus_R_1 50 16 20 Frontal_Inf_Tri_R .6141
232 54 24 Frontal_Mid_Orb_L 22 218 212 ParaHippocampal_R .6089
22 28 40 Frontal_Sup_Medial_L_1 50 16 20 Frontal_Inf_Tri_R .6028
18 266 26 Precuneus_R_1 18 258 14 Precuneus_R .5998
232 54 24 Frontal_Mid_Orb_L 238 16 210 Insula_L .5886
22 28 40 Frontal_Sup_Medial_L_1 18 266 26 Precuneus_R_1 .5701
232 54 24 Frontal_Mid_Orb_L 238 24 24 Frontal_Inf_Orb_L .5643
246 264 4 Temporal_Mid_L 42 18 0 Insula_R_1 .5641
18 258 14 Precuneus_R 34 24 10 Insula_R_2 .5639
42 8 22 Insula_R 238 16 210 Insula_L .5582
18 266 26 Precuneus_R_1 42 10 8 Frontal_Inf_Oper_R .5536
238 16 210 Insula_L 22 218 212 ParaHippocampal_R .5422
42 38 14 Frontal_Mid_R 18 258 14 Precuneus_R .5406
238 24 24 Frontal_Inf_Orb_L 22 218 212 ParaHippocampal_R .5381
18 266 26 Precuneus_R_1 42 38 14 Frontal_Mid_R .5261
246 256 44 Parietal_Inf_L 18 266 26 Precuneus_R_1 .5032
18 258 14 Precuneus_R 212 244 24 Lingual_L_1 .5018
260 252 28 SupraMarginal_L 22 56 18 Frontal_Sup_Medial_L .4981
18 266 26 Precuneus_R_1 236 42 20 Frontal_Mid_L .4848
50 16 20 Frontal_Inf_Tri_R 18 258 14 Precuneus_R .4763
42 18 0 Insula_R_1 232 54 24 Frontal_Mid_Orb_L .4731
50 16 20 Frontal_Inf_Tri_R 34 24 10 Insula_R_2 .4642
260 252 28 SupraMarginal_L 18 266 26 Precuneus_R_1 .463
246 256 44 Parietal_Inf_L 18 258 14 Precuneus_R .4606
18 266 26 Precuneus_R_1 212 244 24 Lingual_L_1 .4585
18 258 14 Precuneus_R 42 18 0 Insula_R_1 .4568
34 24 10 Insula_R_2 232 54 24 Frontal_Mid_Orb_L .4566
246 264 4 Temporal_Mid_L 232 54 24 Frontal_Mid_Orb_L .4565
(Continues)
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TABLE 6 (Continued)
X Y Z Node 1 X Y Z Node 2 r
18 266 26 Precuneus_R_1 34 24 10 Insula_R_2 .4556
260 252 28 SupraMarginal_L 236 42 20 Frontal_Mid_L .4532
260 252 28 SupraMarginal_L 42 10 8 Frontal_Inf_Oper_R .4514
246 264 4 Temporal_Mid_L 238 24 24 Frontal_Inf_Orb_L .4496
22 28 40 Frontal_Sup_Medial_L_1 34 24 10 Insula_R_2 .4469
22 28 40 Frontal_Sup_Medial_L_1 18 258 14 Precuneus_R .4428
42 18 0 Insula_R_1 238 16 210 Insula_L .4418
260 252 28 SupraMarginal_L 18 258 14 Precuneus_R .4415
250 220 12 Temporal_Sup_L_1 212 244 24 Lingual_L_1 .4414
236 42 20 Frontal_Mid_L 50 16 20 Frontal_Inf_Tri_R .439
218 210 216 Hippocampus_L 232 288 216 Lingual_L .4294
18 266 26 Precuneus_R_1 232 54 24 Frontal_Mid_Orb_L .4286
22 28 40 Frontal_Sup_Medial_L_1 42 10 8 Frontal_Inf_Oper_R .4285
18 258 14 Precuneus_R 42 8 22 Insula_R .4272
22 28 40 Frontal_Sup_Medial_L_1 46 4 32 Precentral_R .4258
238 24 24 Frontal_Inf_Orb_L 238 16 210 Insula_L .4241
42 8 22 Insula_R 22 218 212 ParaHippocampal_R .4195
236 42 20 Frontal_Mid_L 22 56 18 Frontal_Sup_Medial_L .4165
236 42 20 Frontal_Mid_L 42 10 8 Frontal_Inf_Oper_R .412
22 28 40 Frontal_Sup_Medial_L_1 236 42 20 Frontal_Mid_L .4078
34 24 10 Insula_R_2 42 8 22 Insula_R .4075
18 266 26 Precuneus_R_1 42 8 22 Insula_R .4063
246 256 44 Parietal_Inf_L 42 10 8 Frontal_Inf_Oper_R .4032
232 288 216 Lingual_L 222 2 226 ParaHippocampal_L .4014
260 252 28 SupraMarginal_L 42 38 14 Frontal_Mid_R .4013
22 28 40 Frontal_Sup_Medial_L_1 42 18 0 Insula_R_1 .398
6 20 28 Cingulum_Ant_R 260 252 28 SupraMarginal_L .3915
246 256 44 Parietal_Inf_L 42 38 14 Frontal_Mid_R .3883
34 24 10 Insula_R_2 238 16 210 Insula_L .385
50 16 20 Frontal_Inf_Tri_R 42 10 8 Frontal_Inf_Oper_R .3831
260 252 28 SupraMarginal_L 212 244 24 Lingual_L_1 .3811
42 18 0 Insula_R_1 22 218 212 ParaHippocampal_R .3802
22 56 18 Frontal_Sup_Medial_L 18 258 14 Precuneus_R .3774
46 4 32 Precentral_R 50 16 20 Frontal_Inf_Tri_R .3773
236 42 20 Frontal_Mid_L 42 38 14 Frontal_Mid_R .3755
246 256 44 Parietal_Inf_L 212 244 24 Lingual_L_1 .3751
18 266 26 Precuneus_R_1 238 16 210 Insula_L .3724
42 38 14 Frontal_Mid_R 250 220 12 Temporal_Sup_L_1 .369
246 256 44 Parietal_Inf_L 260 252 28 SupraMarginal_L .3674
(Continues)
18 | CAUDA ET AL.
finding is further supported by the good correlation between the pat-
terns of anatomical covariance and co-atrophy, especially with regard
to the set of “core areas”.
The inclusion in the MCN analysis of the GM increase data (GM
decrease plus GM increase) leads to a pattern that is fairly similar to
the one found on the basis of GM decrease data only; however, the
former is significantly less similar than the latter to the normal pattern
of anatomical covariance associated with the same nodes. This sug-
gests that GM increase data may contribute to the MCN by adding a
series of edges that are not present in the anatomical covariance pat-
tern. However, it must be observed that, given the little knowledge
with regard to the processes at the root of the increase and decrease
of GM density, the conjoint use of GM decrease and GM increase data
is still a debated issue, which is reflected by different approaches and
positions in the scientific literature (Eickhoff, et al., 2012; Radua &
Mataix-Cols, 2009).
To date, at least four mechanisms have been suggested to explain
how brain abnormalities propagate (Fornito, et al., 2015; Zhou, et al.,
2012), two of which call attention to the role that may be played by
brain architecture. The first mechanism hypothesizes a shared vulner-
ability (caused in particular by the co-expression of genes) between cer-
tain brain areas (Cioli, Abdi, Beaton, Burnod, & Mesmoudi, 2014;
French, Tan, & Pavlidis, 2011; Lichtman & Sanes, 2008; Prieto, Risueno,
Fontanillo, & De las Rivas, 2008; Wolf, Goldberg, Manor, Sharan, &
Ruppin, 2011; Zhou, et al., 2012). The second mechanism posits a
transneuronal spread of misfolded proteins along axonal pathways
TABLE 6 (Continued)
X Y Z Node 1 X Y Z Node 2 r
246 256 44 Parietal_Inf_L 22 56 18 Frontal_Sup_Medial_L .3668
50 16 20 Frontal_Inf_Tri_R 42 8 22 Insula_R .3645
250 220 12 Temporal_Sup_L_1 42 10 8 Frontal_Inf_Oper_R .3595
236 42 20 Frontal_Mid_L 34 24 10 Insula_R_2 .3593
246 256 44 Parietal_Inf_L 236 42 20 Frontal_Mid_L .3556
34 24 10 Insula_R_2 42 10 8 Frontal_Inf_Oper_R .3517
50 16 20 Frontal_Inf_Tri_R 232 54 24 Frontal_Mid_Orb_L .3508
46 4 32 Precentral_R 34 24 10 Insula_R_2 .3501
18 266 26 Precuneus_R_1 42 18 0 Insula_R_1 .3465
236 42 20 Frontal_Mid_L 246 264 4 Temporal_Mid_L .3445
246 264 4 Temporal_Mid_L 22 218 212 ParaHippocampal_R .3404
22 28 40 Frontal_Sup_Medial_L_1 42 8 22 Insula_R .3388
260 252 28 SupraMarginal_L 50 16 20 Frontal_Inf_Tri_R .3388
242 14 0 Insula_L_1 42 8 22 Insula_R .3371
50 16 20 Frontal_Inf_Tri_R 42 18 0 Insula_R_1 .3345
22 220 4 Thalamus_L 42 18 0 Insula_R_1 .3334
34 24 10 Insula_R_2 42 18 0 Insula_R_1 .3312
246 256 44 Parietal_Inf_L 50 16 20 Frontal_Inf_Tri_R .3297
50 16 20 Frontal_Inf_Tri_R 246 264 4 Temporal_Mid_L .3285
22 28 40 Frontal_Sup_Medial_L_1 260 252 28 SupraMarginal_L .3272
236 42 20 Frontal_Mid_L 212 244 24 Lingual_L_1 .3266
236 42 20 Frontal_Mid_L 42 18 0 Insula_R_1 .3239
46 4 32 Precentral_R 250 10 16 Frontal_Inf_Oper_L .3238
42 18 0 Insula_R_1 242 14 0 Insula_L_1 .3231
246 256 44 Parietal_Inf_L 34 24 10 Insula_R_2 .3228
18 258 14 Precuneus_R 232 54 24 Frontal_Mid_Orb_L .3191
50 16 20 Frontal_Inf_Tri_R 22 218 212 ParaHippocampal_R .3132
260 252 28 SupraMarginal_L 34 24 10 Insula_R_2 .3126
42 18 0 Insula_R_1 46 4 32 Precentral_R .3109
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FIGURE 10 Anatomical covariance results. This graph shows the 20 edges showing the highest correlation values (i.e., the couples of most
strongly structurally covariant nodes) [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 11 Anatomical covariance results. The left panel shows the anatomical covariance network results for the same set of nodes employed
in the co-atrophy analysis (GM decreases). Colors and dimensions of nodes indicates their topological degree (smaller node5 lower degree; from
green to red5 from lower to higher values). The right panel shows a spring embedded visualization of the logic AND between the co-atrophy
results and the anatomical covariance network results for the same set of nodes employed in the co-atrophy analysis (i.e., the edges represented
are those that are statistically significant in the co-atrophy AND in the anatomical covariance analysis). Colors and dimensions of nodes indicates
their topological degree (smaller node5 lower degree; from green to red5 from lower to higher values). Colors and dimensions of edges indicates
the degree of edge betweenness (smaller edge5 lower degree; from green to red5 from lower to higher values) [Color figure can be viewed at
wileyonlinelibrary.com]
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connecting different brain regions (Chevalier-Larsen & Holzbaur, 2006;
Fornito, et al., 2015; Goedert, Clavaguera, & Tolnay, 2010; Guest,
et al., 2011; Iturria-Medina, Sotero, Toussaint, & Evans, 2014; Zhou,
et al., 2012). The third mechanism proposes a trophic failure in the neu-
ronal metabolism, that is, a dysfunction of trophic factors that would
disrupt the development and maintenance of neural wiring (Appel,
1981; Fornito, et al., 2015; Salehi, et al., 2006; Zhou, et al., 2012).
Finally, the fourth mechanism hypothesizes that the network hubs
might be more exposed to nodal stress and, thereby, be more suscepti-
ble to pathological modifications (Crossley, et al., 2014; Saxena & Car-
oni, 2011; Zhou, et al., 2012). Probably certain pathological processes
are preferentially involved in some disorders than in others, at least at
their inception. However, it is important to highlight that these four
mechanisms are not mutually exclusive, as different pathological factors
may operate simultaneously.
Of note, all the three psychiatric spectra examined in this study
have been linked to genetic dysfunction. Recently, the risk of develop-
ing SCZD has been associated with variation in the major histocompati-
bility complex locus, in particular in the complement component four
genes (Sekar, et al., 2016). In turn, a number of altered genetic mecha-
nisms have been associated with ASD. In patients with ASD, alterations
of gene expressions might disrupt the autoregulatory feedback of neu-
ronal loops, the brain electrical activity, the concentration of signaling
molecules, as well as the mechanisms of synaptic excitation and inhibi-
tion (Mullins, Fishell, & Tsien, 2016). With regard to OCSD, it has been
suggested that complex patterns of molecular dysfunctions due to
genetic factors (regarding in particular the serotonergic and dopaminer-
gic systems) may account for the familial occurrences of this disorder
(Nestadt, Grados, & Samuels, 2010; Pauls, 2010; Tukel, et al., 2016).
Therefore, studies that aim to understand the genetic patterns of brain
disorders are extremely important and future investigations are needed
to find out whether altered co-expressions of genes can affect the
areas that this meta-analysis has put forward as key nodes in the ana-
tomical co-alteration networking of SCZD, ASD, and OCSD.
Furthermore, proteins such as astrotactins have been suggested
as a common genetic link among these three psychiatric spectra,
because they are fundamental in guiding neurons migration during
brain development (Lionel, Tammimies, Vaags, Rosenfeld, & Ahn,
FIGURE 12 Results comparison of the morphometric co-alteration network for GM increases plus GM decreases, and for GM decreases
only. The left panel shows the morphometric co-alteration network results for GM increases plus GM decreases using an ad hoc developed
set of nodes. The central panel shows the morphometric co-alteration network results for GM increases plus GM decreases using the set of
nodes previously employed for the co-atrophy analysis (see these nodes in Figure 2). The right panel shows the morphometric co-alteration
network results for GM decreases. Colors from blue to red indicates increasing Patel’s k values (i.e., increasing co-alteration probabilities)
[Color figure can be viewed at wileyonlinelibrary.com]
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2014). Oxytocin too—which is a hormone not only associated with
childbirth, milk let-down, and maternal care, but also with the regula-
tion of social behavior and the formation of pair bonds—has been
found to be involved in multiple psychiatric disorders, including
ASD, SCZD, and OCSD. Indeed, in patients with ASD oxytocin
appears to be related to social recognition, attachment, and stereo-
typed behaviors, whereas in patients with SCZD it has been associ-
ated with a potential antipsychotic effect. Interestingly, in patients
with OCSD this hormone has been found to have higher values in
patients that respond to serotonin reuptake inhibitor treatment, but
lower values in patients who have autistic traits (Cochran, Fallon,
Hill, & Frazier, 2013; Humble, Uvnas-Moberg, Engstrom, & Bejerot,
2013; Romano, Tempesta, Micioni Di Bonaventura, & Gaetani,
2015; Shin, et al., 2015; Strauss, et al., 2015).
There are significant symptomatic overlaps between ASD, OCSD,
and SCZD. Between ASD and OCSD common symptoms are insistence
on sameness, tics, ritual and repetitive behaviors. Within SCZD a sub-
type of schizophrenia (schizo-obsessive) is particularly characterized by
obsessive symptoms (Bleich-Cohen, et al., 2014). Of note, the first
diagnostic criterion of DSM-5 for ASD is strictly related to the negative
symptoms of SCZD, while the second diagnostic criterion is similar to
the OCSD symptomatology. The relative symptomatic similarity
between ASD and SCZD is consistent with a neurobiological model
that suggests a common basis for SCZD and ASD, with a number of
genetic alterations (SHANK 3 variations, DISC 1, dysregulation of
CYFIP1, SCN2A, NRXN1 neurexin gene or RELN), cytoarchitectural
abnormalities (about proliferation, migration and lamination defects),
neuropsychological deficit, neuroimaging investigations (about GM/
FIGURE 13 Anatomical covariance results for the GM increases plus GM decreases set of nodes. The upper left panel shows the
anatomical covariance network results for the same set of nodes employed in the co-alteration analysis of GM increases plus GM decreases.
The upper right panel shows the anatomical covariance matrix. The lower left panel shows the logic AND between the co-alteration results
of GM increases plus GM decreases and the anatomical covariance network results for the same set of nodes employed in the analysis of
GM decreases (i.e., the edges represented are those that are statistically significant in the co-atrophy AND in the anatomical covariance
analysis). The lower right panel shows the logic AND between the anatomical covariance matrix and the co-alteration matrix. The correlation
between the two matrices is .1452 (p < .0347). Colors from blue to red indicates increasing correlation values (r) [Color figure can be
viewed at wileyonlinelibrary.com]
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FIGURE 14 Results of the morphometric co-atrophy network by leaving one spectrum out in alternation. This figure shows the comparison
between the results of the morphometric co-atrophy network of the three spectra together (upper left panel) and each of the morphometric
co-atrophy network obtained from leaving one spectrum out in alternation. Colors from blue to red indicates increasing Patel’s k values (i.e.,
increasing co-alteration probabilities) [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 15 Results of the morphometric co-atrophy network (MCN) obtained with an equal number of experiments fro each psychiatric
spectrum. The left panel shows the results obtained with the original dataset. Colors from blue to red indicates increasing Patel’s k values
(i.e., increasing co-alteration probabilities). The central panel shows the overlap between the MCN calculated with the equalized dataset and
the MCN calculated with the original dataset. The right panel shows the stability of the equalized results (analyses were repeated with
1,000 permutations, each time by randomly selecting a different sample of schizophrenia data) expressed in standard error values. Colors
from blue to red indicates increasing standard error values [Color figure can be viewed at wileyonlinelibrary.com]
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WM abnormalities and structural/functional connectivity alterations),
and clinical observations (Baribeau & Anagnostou, 2013; Cauda, et al.,
2017; Cauda, et al., 2014a; Cauda, et al., 2011b; Cheung, et al., 2010;
Chisholm, Lin, Abu-Akel, & Wood, 2015; de Lacy & King, 2013; King &
Lord, 2011; Pathania, et al., 2014).
The psychotic manifestations of SCZD, especially the negative and
catatonic ones, are so much associated with the social withdraw and
communicative difficulty in ASD that even specific tests, such as the
Autism Diagnostic Observation Schedule (ADOS), sometimes fail and
produce false positives if performed on adolescent patients with SCZD
(Bertelli, et al., 2015). Furthermore, psychotic manifestations and ASD
are frequently observed in the clinical practice, and it is particularly
worth noting that some patients, diagnosed with ASD in their child-
hood, show a schizophrenic development in adolescence or adulthood,
accompanied by psychotic and neurodegenerative aspects (Keller, Pie-
dimonte, Bianco, Bari, & Cauda, 2016). These clinical data might be
accounted for by finding out common genetic roots at the basis of neu-
rodevelopment disorders, which bring about phenotypic expressions
with different timings and modalities, due to epigenetic factors affect-
ing the production of proteins with regulatory function over the brain
organization and development (Di Gregorio, et al., 2017). This hypothe-
sis is supported by the clinical examination of families of patients with
ASD, in which phenotypic expressions bear psychiatric disorders differ-
ent from ASD, OCSD, and SCZD (Biamino, et al., 2016). The relation-
ship between genes, epigenetic and environmental factors could
typically emerge from the specific patterns of structural alterations that
our analysis has discovered. In particular, brain hubs are likely to be the
areas in which this relationship appears to be stronger.
Compared to OCSD, structural abnormalities in SCZD and ASD are
especially located in brain areas with a high degree of pathoconnectiv-
ity—that is, areas where altered voxel exhibit a higher degree of con-
nectivity than unaltered voxel—albeit not necessarily in network hubs
with the highest degree of connections. Presumably, factors being spe-
cific to the disorder are likely to determine the regions to be first
affected and how anatomical alterations distribute across the brain
(Crossley, et al., 2016; Crossley, et al., 2014).
As pointed out, frontal and insular cortices are essential parts of the
MCN shared by OCSD, ASD, and SCZD. In particular, fronto-striatal
regions are involved in OCSD, thus supporting the hypothesis that an
orbitofrontal-striatal circuit may be abnormal in OCSD (Cavedini, Riboldi,
Keller, D’annucci, & Bellodi, 2002; Nakao, Okada, & Kanba, 2014).
In both ASD and SCZD, disruption of the loop system of the basal
ganglia is thought to explain impaired sensorimotor access, which
reflects the ability of an organism to filter out irrelevant stimuli. In turn,
the neural circuit composed of the caudate nucleus, the orbitofrontal
cortex, and the anterior cingulate cortex has been reported to play an
important role in OCSD (Chamberlain, Blackwell, Fineberg, Robbins, &
Sahakian, 2005). What is more, the impairment of the anterior cingulate
cortex is supposed to be relevant for causing awareness deficits in
bipolar disorder (Palermo, et al., 2015). Finally, hippocampal disruption
has been associated with both ASD and SCZD (Wible, 2012).
From the clinical point of view, alteration of the areas forming the
MCN may lead to a disruption of social cognition, which is frequently
associated with ASD and SCZD (Bicks, Koike, Akbarian, & Morishita,
2015). Approaches of functional connectivity reveal that specific
parameters of connectivity networks present heritability and are asso-
ciated with familial risk for psychopathology, suggesting a genetic role
not only with regard to psychiatric categories tout court but also with
regard to the brain inter-regional synchronization, thus confirming
liability to broad dimensions of symptomatically related disorders
(Buckholtz & Meyer-Lindenberg, 2012; Caspi, et al., 2014). What is
more, mental illness is generally characterized by polygenic inheritance,
which constantly causes genetic liability. This defies the validity of cat-
egorical models of psychiatric illness and risk, as it implies that brain
disorders can be viewed as the extreme manifestations of normally dis-
tributed quantitative traits (Cauda et al 2017).
The neurobiological substrate of these common alterations may
involve a neurochemical unbalance, especially an alteration in the ratios
of GABA-glutamate on the one hand, and oxytocin-vasopressin on the
other, which could be the targets of specific pharmacological therapies
(Ford, Nibbs, & Crewther, 2017; LeBlanc & Fagiolini, 2011).
If we draw our attention to the altered areas that are not shared
by the three spectra, we see that they can account for differences in
symptomatology. For instance, the more involvement of posterior areas
(sensorimotor and occipito-temporal) in ASD than in SCZD can lead to
a peculiar hypersensitivity for auditory, tactile, and visual stimuli and/or
hyposensitivity for pain stimuli. In turn, a more intense fronto-striatal
alteration characterizes OCSD, thus supporting the hypothesis that an
orbitofrontal-striatal circuit may be abnormal in OCSD (Benzina, Mallet,
Burguiere, N’diaye, & Pelissolo, 2016; Cauda, et al., 2017; Cavallaro,
et al., 2003; Cavedini, et al., 2002).
Several studies have supported a role of neuroinflammation in the
etiology of ASD, SCZD and other brain disorders. In fact, an increased
inflammatory response in the central nervous system is supposed to
activate microglial cells, the activity of which leads to the release of
pro-inflammatory cytokines, including interleukin (IL)-1b, IL-6, and
tumor necrosis factor-a. In turn, pro-inflammatory cytokines aggravate
and propagate neuroinflammation, thus degenerating healthy neurons
and impairing brain functions. Thus, the activated microglia may con-
tribute to the generation of GM abnormalities and, consequently, to
the pathogenesis of psychiatric disorders (Hong, Kim, & Im, 2016).
With regard to SCZD, cortical immune activation and immune-
related markers have been reported in the prefrontal cortex, along with
deficits in the basilar dendritic spines of layer 3 pyramidal neurons and
disturbances in inhibitory inputs to pyramidal neurons. Importantly,
microglia is supposed to regulate excitatory and inhibitory input to
pyramidal neurons (Volk, 2017). Furthermore, differently from SCZD,
the development of ASD appears to be more related to cerebellar dys-
function and subsequent thalamic hyperactivation in early childhood. In
contrast, SCZD seems to be triggered by thalamic hyperactivation in
late adolescence, whereas hippocampal aberration can possibly origi-
nate in childhood. A possible culprits could be found in the metal
homeostasis disturbances, which can induce dysfunction of blood–cer-
ebrospinal fluid barrier. Thalamic hyperactivation is thought to be pro-
duced by microglia-mediated neuroinflammation as well as by
abnormalities of the intracerebral environment. Consequently, it is
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likely that thalamic hyperactivation leads to the dysregulation of the
circuit formed by dorsolateral prefrontal cortex and lower brain regions
related to social cognition (Nakagawa & Chiba, 2016).
All these considerations provide further support for the hypothesis
of a common neurobiological substrate at the basis of diagnostically dif-
ferent psychiatric conditions (Buckholtz & Meyer-Lindenberg, 2012;
Caspi, et al., 2014; Crossley, et al., 2014; McTeague, et al., 2016). Intrigu-
ingly, our findings are consistent with similar results obtained by Good-
kind et al. (2015), which have highlighted the importance of the anterior
insula/dorsal anterior cingulate network as a key circuit that is impaired
by different brain disorders. Both our results and those of Goodkind et al.
are in line with the theoretical proposals suggesting the need for trans-
diagnostic accounts of neuropathological diseases (Buckholtz & Meyer-
Lindenberg, 2012; Caspi, et al., 2014; Crossley, et al., 2014; Douaud,
et al., 2014; Etkin & Cuthbert, 2014; McTeague, et al., 2016; Voytek &
Knight, 2015). The co-alteration networking analysis developed in this
study could play a major role in order to investigate the pathological brain
as well as to lead us to a unifying perspective on neuropathology.
4.1 | Relationship between the co-alteration matrix
and diffusion matrix
At first sight the relationship between the structural co-alteration pat-
tern and the propagation pattern of alterations may seem unclear, as
the two concepts are likely to be considered unrelated. In fact, the for-
mer is straightforwardly associated with a picture of a static event,
which is based on anatomical evidence, while the latter is typically con-
ceived as implying a causal event characterized by a precise temporal
directionality, which can be investigated by longitudinal studies. The
propagation of neuronal abnormalities is a dynamic phenomenon,
which has its onset in certain cerebral areas and then proceeds to
affect other parts of the brain. Cerebral areas appear therefore to be
altered in different temporal sequences, thus originating different prop-
agation patterns. These patterns, however, can be mathematically
described by a Laplacian matrix. What we propose to show is that this
type of matrix can be also obtained from co-alteration meta-analytical
data. Strictly speaking, therefore, although this does not allow to speak
about propagation, it does allow us to interpret the co-alteration pat-
tern as having a network-like architecture.
If we consider two brain areas (populations of neurons): A1 (altered)
and A2 (unaltered) that are structurally connected, then we can say that
the alteration factor, which propagates to A2, is the product of the con-
centration of the alteration factor x1 and the strength of the effective
connectivity c12. Consequently, at a certain time the concentration of the
alteration in A2 is going to increase by a factor of bc12 x22x1ð Þdt, where
b is the diffusion constant that controls the speed of alterations’ spread.
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where L is the Laplacian matrix, which is defined as:
L 5D 2 A
In this equationD is the degree matrix, which is a diagonal matrix con-
taining information about the number of edges attached to every node,
and A is the adjacency matrix, which is a square matrix containing informa-
tion about whether or not pairs of nodes are adjacent or connected.
It can be shown that this formula is the heat equation, which in
turn is a particular case of the diffusion equation, generalized to com-
plex networks (Kondor & Lafferty, 2002). The diffusion equation has
the following explicit solution:
x tð Þ5exp 2bLð Þx0 (1)
This formula defines the evolution of an initial configuration x0 of
a diffusion process.
The Laplacian matrix, needed for the solution of the diffusion
equation, can be derived from the co-alteration matrix of meta-
analytical data. In fact the co-alteration matrix, which can be calculated
in several ways (Crossley et al., 2013), represents the relationship
between the structural alterations of different nodes of a complex net-
work. In our case we determined the co-alteration matrix by using the
Patel’s k, which is an index capable of describing statistically the degree
of association between nodes (Patel et al., 2006) see Section 2 for
more details). The final result is a square and symmetric matrix, which
is tantamount to the adjacency matrix A containing in its rows and col-
umns the nodes of the complex network. This is nothing but a connec-
tion matrix, from which it is possible to obtain the degree matrix D and,
thereby, derive the Laplacian matrix L, which eventually allows to con-
struct the diffusion dynamics of the complex network.
We can see clearly now that there is a strict mathematical relation-
ship between propagation pattern (causation) and co-alteration pattern,
as it is possible to obtain from co-alteration data the diffusion matrix of
the alterations. In fact, the Laplacian matrix of Equation 1 may allow us
to create a temporal description of the alterations’ spread. What we
need is just an initial node, in which alterations begin to accumulate
(start condition x0); from that point of onset we therefore could see
how alterations propagate in time and space through the sequence of
the progressively altered nodes. Still, the analysis of meta-analytical
data of co-alterations cannot permit to identify the onset of the altera-
tion process (initial nodes). Therefore, we can say that alterations diffuse
from nodes to nodes, but we cannot describe the progression of this
diffusion. This is why in the article we refer to the diffusion of altera-
tions in the terms of “distribution” rather than “spread” or “propagation”.
However, on the grounds of the mathematical considerations stated
above, we can confidently hold that the co-alteration pattern resulted
from our analyses is to be interpreted as a network-like phenomenon.
4.2 | Limitations
The meta-analysis presented here has been carefully designed. How-
ever, some critical aspects should be recognized. The first aspect
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regards the literature search, in which a good number of potential stud-
ies have been identified but others could have been missed. The sec-
ond aspect regards the heterogeneity of group subjects (different for
age and gender) that participated in the studies retrieved for this meta-
analysis, which could be a possible confounding factor.
The third aspect concerns the fact that the sample used to cal-
culate the anatomical covariance obviously differ from the sample
used to calculate the MCN; in other words, it must always bear in
mind that these analyses are derived from two different populations
and, importantly, from different types of data, native ones on the
one hand, and meta-analytical ones on the other. As meta-analytical
data are aggregated for groups of subjects, we are not able to distin-
guish possible differences due to either the healthy population or
the pathological one. However, it is very unlikely that these differen-
ces could increase the number of false positives; in contrast, it is
much more likely that they could increase the number of false
negatives.
The fourth aspect concerns the greater representativeness of
SCZD with respect to the other two spectra, which could lead to think
that our results are considerably driven by SCZD data. However, the
further analyses discussed in the paragraph “Reliability” address this
limitation and make it unlikely for the following considerations. (1)
Edges co-alteration values of ASD and OCSD are somewhat similar to
those of SCZD. (2) The MCN calculated without SCZD data is very sim-
ilar to the MCN calculated by using all the data of the three spectra. (3)
GM alterations are not specific to a particular spectrum but tend to be
subsumed into two clusters within which they distribute rather homo-
geneously (see Supporting Information, Figure S3). (4) Apart from the
inevitable differences due to the reduced sample, the MCN obtained
by equalizing the number of experiments for each psychiatric spectrum
largely overlaps the MCN obtained by using the whole original dataset
(Dice coefficient5 .7969; see Figure 15). This result is very encourag-
ing, as the new MCN overlaps for the most part the original MCN, thus
making much less likely that the analysis on the whole dataset is largely
driven by SCZD data.
Of course we cannot completely exclude that the numerousness
of the SCZD sample somehow influenced the MCN pattern but, taken
together, all the reliability results lead us to think that most of the
MCN actually represents an alteration pattern that is common to the
three neuropsychiatric spectra. Finally, it is worth noting that one of
the main goals of our work is to demonstrate that it is possible to
investigate anatomical co-alteration patterns related to neuropsychiat-
ric/neurological conditions by using techniques that are based on the
conditional probability. Given that the application of this methodology
is new, we preferred to test it on as many data as possible; the union
of these data was allowed by transdiagnostic considerations as well as
by a previous publication of our research group (Cauda et al., 2017), in
which we showed that SCZD, ASD and OCSD share a significant set of
neuronal alterations. Still, other studies are needed to confirm the
hypothesis that different psychiatric conditions share brain alteration
patterns with the help of different methodologies and other data
whose source is not meta-analytical.
5 | CONCLUSIONS
This meta-analysis was able to address the following important issues.
1. In SCZD, ASD, and OCSD GM alterations do not distribute ran-
domly across the brain but rather follow identifiable patterns of
co-alteration.
2. These patterns exhibit a network-like architecture, forming an
ensemble of co-altered areas that can be defined as morphometric
co-atrophy network or MCN, along with the structural and func-
tional pathways linking these areas, which in turn can be defined
as pathoconnectivity.
3. Within the MCN it is possible to identify certain cerebral areas,
which can be thought of as pathoconnectivity hubs according to
their network degree or level of connectivity with every other co-
altered area. The alteration of these hubs is supposed to lead to a
faster and more diffuse distribution of neuronal abnormalities
across the brain.
4. Within the MCN it is also possible to identify a “core” subnet-
work of co-altered areas, encompassing insular, prefrontal, tha-
lamic, parahippocampal, superior temporal and precentral
regions.
5. A normal pattern of anatomical covariance is also associated with
the MCN areas. In part the MCN and the anatomical covariance
pattern overlap, which suggests that brain disorders may influence
and alter the development of the anatomical covariance by modi-
fying preexisting structural covariances as well as producing other
pathological ones (co-alterations).
The new methodology of morphometric co-alteration network analysis
developed in this study, as well as the possibility to implement this
analysis on huge databases, promises to open exciting prospects for
the understanding of the pathological brain. A growing body of
research is developing around the hypothesis that the brain is altered
on the basis of its neural organization. Therefore, the development of a
valuable connectomic approach to the co-alteration of structural and
functional neuronal abnormalities is essential for understanding better
the dynamic of brain disorders (Fornito et al., 2015). Also, from the eti-
ological point of view, neuroanatomical alterations may be associated
with a pathologically increased neuroinflammatory response. Future
investigations into this line of research are promising to shed new light
on how the brain responds to illness as well as on how brain diseases
can be influenced by the cerebral structural and functional organiza-
tion. This important knowledge will help the clinical practice to achieve
a better predictive diagnostic power and improve medical care and
treatment.
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